Trials / Completed
CompletedNCT04825431
Mass Balance Study of [14C] TAS-205 in Healthy Volunteers
A Phase 1 Open-label Study Evaluating the Pharmacokinetics and Mass Balance of [14C] TAS-205 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Taiho Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 39 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the pharmacokinetics, mass balance recovery, metabolite profile and metabolite identification of \[14C\]TAS-205 following oral single doses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TAS-205, [14C]TAS-205 | single oral administration under fasted conditions on day 1 |
Timeline
- Start date
- 2021-03-22
- Primary completion
- 2021-06-15
- Completion
- 2022-05-27
- First posted
- 2021-04-01
- Last updated
- 2022-08-08
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04825431. Inclusion in this directory is not an endorsement.